All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
  TRANSLATE

The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

When is it safe to schedule an allo-HSCT after COVID-19 infection?

During the virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Maximilian Christopeit, University Hospital Tübingen, Tübingen, DE. We asked, When is it safe to schedule an allo-HSCT after COVID-19 infection?

When is it safe to schedule an allo-HSCT after COVID-19 infection?

Christopeit states that we should schedule allo-HSCT as late as possible. He then provides data on overall survival for patients with cancer following COVID-19 detection, and the relationship between immunocompromised hosts and time of being infectious. He concludes with the UKE Hamburg experience, a study investigating the safety of allo-HSCT transplant following intensive conditioning in patients with previous COVID-19.

 

Share: